Hippocampal formation glucose metabolism and volume losses in MCI and AD

被引:455
作者
De Santi, S
de Leon, MJ
Rusinek, H
Convit, A
Tarshish, CY
Roche, A
Tsui, WH
Kandil, E
Boppana, M
Daisley, K
Wang, GJ
Schlyer, D
Fowler, J
机构
[1] NYU, Sch Med, Dept Psychiat, New York, NY 10012 USA
[2] NYU, Sch Med, Dept Radiol, New York, NY USA
[3] Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA
[4] Brookhaven Natl Lab, Dept Med, Upton, NY 11973 USA
[5] Brookhaven Natl Lab, Dept Chem, Upton, NY 11973 USA
关键词
PET; MRI; mild cognitive impairment; early diagnosis of Alzheimer's disease hippocampal formation;
D O I
10.1016/S0197-4580(01)00230-5
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
We used MRI volume sampling with coregistered and atrophy corrected FDG-PET scans to test three hypotheses: 1) hippocampal formation measures are superior to temporal neocortical measures in the discrimination of normal (NL) and mild cognitive impairment (MCI); 2) neocortical measures are most useful in the separation of Alzheimer disease (AD) from NL or MCI: 3) measures of PET glucose metabolism (MRglu) have greater diagnostic sensitivity than MRI volume. Three groups of age, education, and gender matched NL, MCI, and AD subjects were studied. The results supported the hypotheses: 1)entorhinal cortex MRglu and hippocampal volume were most accurate in classifying NL and MCI: 3) both imaging modalities identified the temporal neocortex as best separating MCI and AD, whereas widespread changes accurately classified NL and AD: 3) In most between group comparisons regional MRglu measures were diagnostically superior to volume measures. These cross-sectional data show that in MCI hippocampal formation changes exist without significant neocortical changes. Neocortical changes best characterize AD. In both MCI and ADI metabolism reductions exceed volume losses. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:529 / 539
页数:11
相关论文
共 102 条
[1]   Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease [J].
Albin, RL ;
Minoshima, S ;
DAmato, CJ ;
Frey, KA ;
Kuhl, DA ;
Sima, AAF .
NEUROLOGY, 1996, 47 (02) :462-466
[2]  
ALPERT NM, 1990, J NUCL MED, V31, P1717
[3]  
Amaral D.G., 1990, HUMAN NERVOUS SYSTEM, P711, DOI 10.1016/C2009-0-02721-4
[4]   DISTRIBUTION OF ALZHEIMER-TYPE PATHOLOGICAL-CHANGES IN NONDEMENTED ELDERLY INDIVIDUALS MATCHES THE PATTERN IN ALZHEIMERS-DISEASE [J].
ARRIAGADA, PV ;
MARZLOFF, K ;
HYMAN, BT .
NEUROLOGY, 1992, 42 (09) :1681-1688
[5]  
Berent S, 1999, J PSYCHIAT RES, V33, P7
[6]   NEUROPATHOLOGICAL INDEXES OF ALZHEIMERS-DISEASE IN DEMENTED AND NONDEMENTED PERSONS AGED 80 YEARS AND OLDER [J].
BERG, L ;
MCKEEL, DW ;
MILLER, JP ;
BATY, J ;
MORRIS, JC .
ARCHIVES OF NEUROLOGY, 1993, 50 (04) :349-358
[7]   MRI of entorhinal cortex in mild Alzheimer's disease [J].
Bobinski, M ;
de Leon, MJ ;
Convit, A ;
De Santi, S ;
Wegiel, B ;
Tarshish, CY ;
Saint Louis, LA ;
Wisniewski, HM .
LANCET, 1999, 353 (9146) :38-40
[8]   NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES [J].
BRAAK, H ;
BRAAK, E .
ACTA NEUROPATHOLOGICA, 1991, 82 (04) :239-259
[9]   NEUROFIBRILLARY CHANGES CONFINED TO THE ENTORHINAL REGION AND AN ABUNDANCE OF CORTICAL AMYLOID IN CASES OF PRESENILE AND SENILE DEMENTIA [J].
BRAAK, H ;
BRAAK, E .
ACTA NEUROPATHOLOGICA, 1990, 80 (05) :479-486
[10]   AGE-RELATED-CHANGES IN BRAIN .1. MAGNETIC-RESONANCE-IMAGING MEASURES OF TEMPORAL-LOBE VOLUMES IN NORMAL SUBJECTS [J].
CONVIT, A ;
DELEON, MJ ;
HOPTMAN, MJ ;
TARSHISH, C ;
DESANTI, S ;
RUSINEK, H .
PSYCHIATRIC QUARTERLY, 1995, 66 (04) :343-355